Mrna vaccines against sars-cov-2 induce comparably low long-term igg fc galactosylation and sialylation levels but increasing long-term igg4 responses compared to an adenovirus-based vaccine

HIGHLIGHTS

• who: Jana Sophia Buhre and collaborators from the Pfizer, United States Saint Louis University, United States have published the article: mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine, in the Journal: (JOURNAL)
• what: The authors present a comprehensive analysis of serum-derived and salivary anti-S1 IgG (subclass) and IgA Ab responses as well as anti-S serum IgG1 Fc N-glycosylation patterns of SARS-CoV2 nau00efve and pre-infected individuals vaccinated with different . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.